Incidence, right vs ≥159 ≤151 1.04 (0.80-1.36) colon, women cm Incidence, colon vs ≥159 ≤151 1.24 (1.04-1.47) cancer, women cm Incidence, colorectal 1.23 (0.84-1.79) cancer, 2 Q 3 vs Q 1 Ptrend:0.28 genes NLCS, Age, sex, Simons, 2014 204/ methylated Case Cohort, Gene COL41029 Cancer registry Questionnaire Age: 55-69 physical methylation data Incidence, Netherlands years activity, weight colorectal cancer, Igfbp 2 per 5 cm 1.05 (0.93-1.19) genes methylated Incidence, Q 3 vs Q 1 1.24 (1.05-1.47) 1 142/ cancer 56 064 Incidence, per 10 cm 1.10 (0.99-1.22) cancer Life Span Semmens, 2013 Participants are Prospective Age, sex, city Incidence, colon 153-155 vs ≤149 COL40929 Cancer registry Self-reported atomic bomb 577/ 1.27 (0.99-1.63) Cohort, attained age cancer, women cm Japan survivors M/W Incidence, 164-168 vs ≤160 565/ 1.23 (0.97-1.55) cancer, men cm Incidence, 565/ per 10 cm 1.06 (0.92-1.23) cancer, men
Incidence, right colon, women ≥159 vs ≤151 cm 1.04 (0.80-1.36) Incidence, colon cancer, women ≥159 vs ≤151 cm 1.24 (1.04-1.47) Simons, 2014 COL41029 Netherlands NLCS, Case Cohort, Age: 55-69 years 204/ Cancer registry Questionnaire Incidence, colorectal cancer, 2 genes methylated Q 3 vs Q 1 1.23 (0.84-1.79) Ptrend:0.28 Age, sex, physical activity, weight Gene methylation data Incidence, colorectal cancer, Igfbp 2 genes methylated per 5 cm 1.05 (0.93-1.19) Semmens, 2013 COL40929 Japan Life Span Prospective Cohort, M/W 1 142/ 56 064 Cancer registry Self-reported Incidence, cancer Q 3 vs Q 1 1.24 (1.05-1.47) Age, sex, city attained age Participants are atomic bomb survivors Incidence, cancer per 10 cm 1.10 (0.99-1.22) 577/ Incidence, colon cancer, women 153-155 vs ≤149 cm 1.27 (0.99-1.63) 565/ Incidence, cancer, men 164-168 vs ≤160 cm 1.23 (0.97-1.55) 565/ Incidence, cancer, men per 10 cm 1.06 (0.92-1.23)
CUP_colorectal_SLR_2016_RO.docx